IE
OTLK icon

Israel Englander’s Outlook Therapeutics OTLK Stock Holding History

Israel Englander’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92K Buy
+57,839
New +$35.9K ﹤0.01% 5517
2026
Q1 		– Sell
-164,498
Closed -$260K – 6193
2025
Q4 		$260K Sell
164,498
-30,085
-15% -$48.1K ﹤0.01% 5340
2025
Q3 		$206K Sell
194,583
-143,988
-43% -$249K ﹤0.01% 5533
2025
Q2 		$542K Buy
+338,571
New +$540K ﹤0.01% 4852
2024
Q2 		– Sell
-27,744
Closed -$331K – 6356
2024
Q1 		$331K Buy
27,744
+13,965
+101% +$113K ﹤0.01% 5074
2023
Q4 		$109K Buy
+13,779
New +$116K ﹤0.01% 5328
2023
Q3 		– Sell
-7,187
Closed -$250K – 6434
2023
Q2 		$250K Sell
7,187
-18,587
-72% -$507K ﹤0.01% 5007
2023
Q1 		$562K Buy
25,774
+17,064
+196% +$382K ﹤0.01% 4528
2022
Q4 		$188K Buy
8,710
+2,068
+31% +$45K ﹤0.01% 5356
2022
Q3 		$162K Sell
6,642
-7,883
-54% -$183K ﹤0.01% 5770
2022
Q2 		$296K Sell
14,525
-3,347
-19% -$96.2K ﹤0.01% 5385
2022
Q1 		$636K Sell
17,872
-7,331
-29% -$229K ﹤0.01% 4924
2021
Q4 		$686K Sell
25,203
-22,810
-48% -$814K ﹤0.01% 4764
2021
Q3 		$2.08M Buy
+48,013
New +$2.32M ﹤0.01% 3853
2021
Q2 		– Sell
-10,001
Closed -$450K – 6941
2021
Q1 		$450K Buy
10,001
+971
+11% +$37.2K ﹤0.01% 4906
2020
Q4 		$235K Buy
+9,030
New +$189K ﹤0.01% 4717
2017
Q3 		– Sell
-196
Closed -$31K – 3767
2017
Q2 		$31K Sell
196
-102
-34% -$28.8K ﹤0.01% 3377
2017
Q1 		$128K Sell
298
-70
-19% -$34.8K ﹤0.01% 3298
2016
Q4 		$177K Sell
368
-160
-30% -$89.6K ﹤0.01% 3110
2016
Q3 		$359K Sell
528
-23
-4% -$14.6K ﹤0.01% 2749
2016
Q2 		$300K Buy
+551
New +$329K ﹤0.01% 2725

Other funds holding OTLK

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GWM
Gilpin Wealth Management Denver, Colorado $145M AUM

Israel Englander's OTLK Position: Q2 2026 in Review

Israel Englander opened a new position in Outlook Therapeutics (OTLK) in Q2 2026: 57,839 shares worth $92K. The stake represents ﹤0.01% of the portfolio and ranks #5517 among its holdings. This is a return to the name: Israel Englander previously reported a position in OTLK as recently as Q4 2025.

Israel Englander first reported a position in OTLK in Q2 2016 and has held it in 21 quarters since. The position peaked at $2.08M in Q3 2021. 70 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.

  • Israel Englander held 57,839 shares of Outlook Therapeutics worth $92K as of Q2 2026.
  • Outlook Therapeutics was a new Israel Englander position in Q2 2026.
  • Outlook Therapeutics made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5517 holding.
  • Israel Englander first reported a position in Outlook Therapeutics in Q2 2016 and has held it in 21 quarters since.
  • Israel Englander's Outlook Therapeutics position peaked at $2.08M in Q3 2021.
  • 70 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.